Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biomet Orthopedics, LLC
This is a 10 year prospective data collection documenting the function and survivorship of the M2a-Magnum™ Hip System. Patients are required to come in for preoperative, operative, one year follow-up, three year follow-up, five year follow-up, and ten year follow-up exams.
This product was FDA cleared in 2004.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non-inflammatory degenerative joint disease including: Avascular Necrosis, Diastrophic Variant, Fracture of the Pelvis, Fused Hip, Leg Perthes, Osteoarthritis, Slipped Capital Epiphysis, Subcapital Fractures, Traumatic Arthritis
Rheumatoid Arthritis
Correction of Functional Deformity
Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
Revision of previously failed total hip arthroplasty
You may not be if
Absolute contraindications include:
Infection, Sepsis, and Osteomyelitis
Relative contraindications include:
Uncooperative patient or patient with neurologic disorders that are incapable of following directions
Osteoporosis
Metabolic disorders which may impair bone formation
Osteomalacia
Distant foci of infections which may spread to the implant site
Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
Vascular insufficiency, muscular atrophy, or neuromuscular disease